[177Lu]-CTT-1403

N/A

Report date: 2025/09/24 17:41:41

NME

Base Information

Drug Name[177Lu]-CTT-1403

Drug Alias NameCTT-1403[177Lu]CTT1403177Lutetium CTT1403[177Lu]CTT-1403

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCancer Targeted Technology Llc

China Registration ClassN/A

Develop Information

Active CompaniesCancer Targeted Technology Llc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A